OTC and ornithine carbamoyltransferase deficiency: To achieve adequate control of severe hyperammonaemia in the OTCD mouse model, therefore, requires a much higher than expected dose of AAV2/8 vector carrying OTC transgene, which might be explained by the non-physiological pattern of liver transduction (Cunningham et al 2011).